Company Filing History:
Years Active: 2001-2008
Title: The Innovations of Noel Boyle
Introduction
Noel Boyle is an accomplished inventor based in Cliffside Park, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of receptor research. With a total of 3 patents to his name, Boyle's work has the potential to impact various medical applications.
Latest Patents
Boyle's latest patents focus on the mammalian SNORF25 receptor. The first patent provides isolated nucleic acids encoding mammalian SNORF25 receptors, along with purified receptors, vectors, and cells that comprise these vectors. It also includes antibodies directed to the receptors, nucleic acid probes for detection, and antisense oligonucleotides that are complementary to unique sequences of the encoding nucleic acid. Furthermore, it outlines methods for isolating the receptors, treating abnormalities linked to their activity, and identifying compounds that bind to them. The second patent mirrors these innovations, emphasizing the methods of identifying agonists and antagonists of SNORF25 receptors.
Career Highlights
Throughout his career, Noel Boyle has worked with notable companies such as Synaptic Pharmaceutical Corporation and H. Lundbeck A/S. His experience in these organizations has allowed him to refine his expertise in receptor research and biotechnology.
Collaborations
Boyle has collaborated with esteemed colleagues, including James A. Bonini and Beth E. Borowsky. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Noel Boyle's contributions to the field of biotechnology, particularly through his patents on the SNORF25 receptor, showcase his innovative spirit and dedication to advancing medical science. His work continues to pave the way for future discoveries in receptor biology.